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Ling-hui Qu1, Xin Jin1,2, Liang-mao Li3, Shi-ying Li1* and Han-ping Xie1*Abstract
Background: Previous studies indicated that hyperlipidemia was associated with retinitis pigmentosa (RP). We
aimed to identify the mutations in the C5L2 gene which was reported to be associated with hyperlipidemia in a
Chinese family with (RP).
Methods: The Proband from the family was screened for mutations in the C5L2 gene that was known to cause
hyperlipidemia. Cosegregation analysis was performed in the available family members. Linkage analysis was
performed for one missense mutation to calculate the likelihood of its pathogenicity. One hundred and fifty
unrelated, healthy Chinese subjects were screened to exclude nonpathogenic polymorphisms.
Results: By direct sequencing method, we identified a novel mutation (Thr196Asn) in C5L2 gene. In this family,
each affected family members with RP showed a heterozygous mutation in the C5L2 gene. And all the carriers with
heterozygous mutation have increased serum lipid levels in this family.
Conclusions: The present study has extended the mutation spectrum of C5L2, and Thr196Asn mutations in C5L2
were associated with RP and serum lipid levels.
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Retinitis pigmentosa (RP) is a hereditary retinal degen-
eration of unknown etiology, resulting in progressive
night blindness, loss of peripheral vision, abnormal
retinal pigmentation and reduced electroretinographic
response [1]. Nonsyndromic RP is the most common
inherited form of severe retinal degeneration, with a
prevalence of approximately 1/4,000 RP cases world-
wide [1]. Nonsyndromic cases can be inherited as an
autosomal-dominant (20%–25%), autosomal-recessive
(15%–20%), X-linked recessive (10%–15%), or sporadic/
simplex (30%) trait [2].
Although there are more than 55 genes have been
reported to be associated with RP, the mechanism of
RP remains unclear. The previous studies suggested
that lipid metabolism was abnormal in patients with* Correspondence: zhengqin@163.com; xiehanping955@163.com
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unless otherwise stated.RP [3,4]. And Fujita et al. reported an association between
a missense coding region polymorphism Asn985Tyr in
the retinitis pigmentosa 1 gene (RP1), a causal gene for
RP, and plasma triglyceride (TG) levels in 332 adult
Japanese [5]. These evidences suggested that abnormal
metabolism of lipids may be associated with the RP
patients. C5L2 is a G protein-coupled receptor (GPCR)
and was demonstrated to be a functional receptor of
acylation-stimulating protein (ASP) [6-8]. ASP is also
known as C3a des-Arg, a stimulator of TG synthesis
[9-12] or glucose transport [13,14]. Previous study sug-
gested that genetic mutation of C5L2 was associated
with hyperlipidemia [15,16]. Therefore, we hypotheses
that the mutation in C5L2 gene is associated with risk
for RP.
In the present study, we aimed to identify novel mu-
tations in C5L2 gene in a RP family and to analyze the
relation between this mutation and RP.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Recruitment of subjects
All participants were identified at Southwest Eye Hospital,
the General Hospital of Chinese People’s Liberation Army.
The diagnosis of RP was based on the presence of
night blindness, typical fundus findings (characteristic
retinal pigmentation, vessel attenuation, and various
degrees of retinal atrophy), the severe loss of periph-
eral visual field, and abnormal electroretinogram
(ERG) findings (dramatic diminution in amplitudes or
the complete absence of response). Figure 1(A) showed
the fundus pictures of the right (R) and left eye (L)
of the index patient. ERG testing showed non-recordable
responses (Figure 1B). This study was approved by
the Institutional Review Board of Southwest Hospital,
the General Hospital of Chinese People’s Liberation
Army and adhered to the tenets of the Declaration of
Helsinki and the Guidance on Sample Collection of
Human Genetic Diseases by the Ministry of Public Health
of China.Clinical evaluations
For each patient, a full medical and family history was
taken and an ophthalmological examination was per-
formed. Each underwent a standard ophthalmic exam-
ination: best correct visual acuity according to Snellen
charts, slit-lamp biomicroscopy, dilated indirect ophthal-
moscopy, fundus photography if possible, and visual
field tests (Octopus; Interzeag, Schlieren, Switzerland).
Retinal structure was examined by using optical coher-
ence tomography (OCT; Topcon, Tokyo, Japan). ERGs
were performed (RetiPort ERG system; Roland Consult,
Wiesbaden, Germany) using corneal “ERGjet” contactFigure 1 Morphological findings. A. Fundus pictures of the right (R) and
vessels, and characteristic pigment changes in the mid-periphery. B. ERG telens electrodes. The ERG protocol complied with the
standards published by the International Society for
Clinical Electrophysiology of Vision.
Biochemical analysis
Serum concentrations of total cholesterol (TC), Triglyc-
erides (TG), glucose, high-density lipoprotein cholesterol
(HDL-C), Low-density lipoprotein cholesterol (LDL-C)
were measured using standard methods.
Genetic studies
Genomic DNA was extracted from the peripheral
white blood cells. We used 2ml blood which collected
in EDTA vacutainer tubes. Genomic DNA was isolated
from the peripheral leukocytes by using a QIAamp
DNA Blood Midi Kit (Qiagen, Hilden, Germany) ac-
cording to the manufacturer’s protocol. All 2 coding
exons of the C5L2 gene were sequenced. Sequence in-
formation for use as a reference template was obtained
from the Ensembl Genome Browser (Human, number
ENSG00000134830). Sequencing primers were described
by Zheng et al. [15,16]. The sense primer was 5′
AAGATGCCACTTCTA ACAACA3′ and the antisense
primer was 5′GTTGAATGAAGGAAGGAATAA3′. The
PCR procedure was described previously [16]. Briefly,
the polymerase chain reaction (PCR) was undertaken
with 50 ng of genomic DNA in a 20 μL reaction con-
taining 10 μL of Power Mix (Beijing Biotech, Beijing,
China), 9.5 μL of distilled water, and 0.2 mM of each
forward and reverse primer. A GeneAmp 9700 thermal
cycler (Applied Biosystems, Foster City, CA, USA) was
used for PCR amplification. An initial denaturation
step at 95°C for 5 min, 40 cycles of 95°C for 30 s, 56°Cleft eye (L) of the index patient showing pallor optic discs, attenuated
sting showed extinguished rod response.
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tension step of 72°C for 10 min. A 1615-base pair (bp)
product was amplified was purified using ExoSAP-IT
(Amersham Biosciences) according to manufacturer’s
instructions before it was used as a template for se-
quencing. Sequencing reactions were undertaken by
BGI-Beijing (Beijing, China; http://www.genomics.cn).Statistical analysis
Data were analyzed using SPSS software 13.0. Statis-
tical significance was accepted at p < 0.05. Values were
expressed as mean ± SD for serum concentrations of
TC, TG, HDL-C and LDL-C. Student’s t-test was per-
formed to compare serum lipids levels between mutation
carriers and wild carriers.Results
Mutation analysis
Upon complete sequence analysis of the coding re-
gions of C5L2, three mutations were detected in four
(RP patients) out of 16 family members, including
one novel missense mutation (Thr196Asn) and two
previously reported missense mutation (Pro233Leu,
and rs36046934). The missense mutation c.587C>A in
exon 1 resulted in a substitution of asparagine for threo-
nine at codon 196 (Thr196Asn). This novel mutation
(Thr196Asn) has not been found in 150 unrelated healthy
subjects.The relation between novel mutation and RP
In this family, we found all these four patients with RP
were carriers of 196Asn allele, but the else 10 unaffected
members were not carriers with 196Asn allele (Figures 2
and 3).Figure 2 Pedigree of the Chinese family with retinitis pigmentosa ass
beneath the symbols. Affected individuals are represented by black symbo
Arrows mark the index patients. M refers to the mutant allele, and +meansThe relation between novel mutation and lipids level
In this family, we also found the carriers with 196Asn
allele have higher levels of TG (2.9 ± 1.3 mmol/L) and
LDL-C (5.1 ± 1.4) (p < 0.05). However, the subjects
without 196Asn allele have lower levels of serum lipids
(TG, 1.6 ± 0.4; LDL-C, 3.3 ± 1.1) (p < 0.05) (Figure 4).
Discussion
In the present study, we identified a novel missense muta-
tion (Thr196Asn) in a RP family, and found this variant
affects the risk for RP and hypertriglyceridemia. This is
the first study to identify a novel mutation and analyze the
relation between this mutation and RP.
The foundation for human studies examining putative
causative genes that may be involved in RP is based on a
candidate gene approach. A few studies into the genetic
polymorphisms of the C5L2 receptor located on chromo-
some 19q13 (the region identified to be associated with
familial combined hyperlipidemia and the pre-diabetic
state by genome-wide scan studies) have been completed
[17,18]. Familial combined hyperlipidemia is considered
to be the most frequent lipoprotein disorder in RP [3-5].
Therefore, the C5L2 gene is thought to be a candidate
gene for RP.
In the present study, we identified three missense muta-
tions in a family with RP. The Pro233Leu mutation was
found by Zheng et al. in coronary artery disease (CAD)
patient. Zheng et al. found the Pro233Leu variant was
associated with CAD and Type 2 diabetes. The other
variant- rs36046934 have been recorded in the NCBI
database (http://www.ncbi.nlm.nih.gov/SNP). Therefore,
in the present study, we did not analyze the relation be-
tween these two variants and RP. As for the mutation
Thr196Asn, we did not find in 150 unrelated healthy sub-
jects, which indicated that this mutation is a rare variant.
In this RP family, all these four patients with RP have thisociated with mutations in the C5L2 gene. Genotypes are shown
ls, unaffected ones by unfilled; squares signify males, circles females.
normal allele.
Figure 3 The DNA sequence around the mutation site. A: Mutation sequence; B: wild sequence.
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not this mutation, which suggested that the Pro233Leu
variant is a causative mutation for RP in this family.
In addition, we also found the Pro233Leu variant was
associated with increased TG and LDL-C levels in this
family. However, the mechanisms may link to the RP andFigure 4 Comparation between mutation carrier and wild carrier in seabnormal lipid level resulting from the C5L2 mutation is
unclear and is worth exploring in the future.
Conclusion
In conclusion, the C5L2 may be a causative gene for RP
with hyperlipidemia.rum lipids levels. A: TG; B: TC; C: LDL-C; D: HDL-C
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